Lumira Capital Investment Management Inc.

Insider Reports History

Entity
Company
Location
141 Adelaide Street West, Suite 770, Toronto, Ontario, Canada
Signature
/s/ Vasco Larcina, CFO of Lumira Capital Investment Management Inc.
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Lumira Capital Investment Management Inc.:

Stock Role Class Num Shares Value Price $ Report Date Ownership
enGene Holdings Inc. 10%+ Owner Common Shares 1.34M $13.4M $10.00 Feb 20, 2024 Held by Lumira Ventures III, L.P.
enGene Holdings Inc. 10%+ Owner Common Shares 1.08M $10.8M $10.00 Feb 20, 2024 Held by Merck Lumira Biosciences Fund, L.P.
enGene Holdings Inc. 10%+ Owner Common Shares 994K $9.94M $10.00 Feb 20, 2024 Held by Lumira Ventures IV, L.P.
enGene Holdings Inc. 10%+ Owner Common Shares 239K $2.39M $10.00 Feb 20, 2024 Held by Lumira Ventures IV (International), L.P.
enGene Holdings Inc. 10%+ Owner Common Shares 153K $1.53M $10.00 Feb 20, 2024 Held by Merck Lumira Biosciences Fund (Quebec), L.P.
enGene Holdings Inc. 10%+ Owner Common Shares 44.6K $446K $10.00 Feb 20, 2024 Held by Lumira Ventures III (International), L.P.

Insider Reports Filed by Lumira Capital Investment Management Inc.

Symbol Company Period Transactions Value $ Form Type Date Filed Role
ENGN enGene Holdings Inc. Feb 20, 2024 2 $8M 4 Feb 21, 2024 10%+ Owner
ENGN enGene Holdings Inc. Oct 31, 2023 0 $0 3 Nov 7, 2023 10%+ Owner